Norbudrine

This classification denotes a beta-adrenergic agonist with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8P6T83567P, chemically known as 2-cyclobutylamino-1-(3,4-dihydroxyphenyl)ethanol but generally known as norbudrine, which bears US NIH Compound Identifier 166575. European Medicines Agency schedules Norbudrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09355MIG. The term NORBUDRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). NORBUDRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule norbudrine under HS 29225000 and SITC 51467. As of Q4 2014, NORBUDRINE remains the US FDA Preferred Term for this commodity. Norbudrine bears US NLM identifiers UMLS ID C2698494 and NCI Concept Code C76542. SMILES: C1CC(C1)NCC(C2=CC(=C(C=C2)O)O)O.